(Q46808081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Abegale W Hartfield

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Nicholas A Moore

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

2 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1938-1945

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292324%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300949

9 January 2020

exact match

0 references

cites work

Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Serum leptin levels increase rapidly after initiation of clozapine therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Serotonergic and histaminergic mechanisms involved in intralipid drinking?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Studies on modulation of feeding behavior by atypical antipsychotics in female mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Free-feeding and free-drinking patterns of male rats following treatment with opiate kappa agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Switch from neuroleptics to clozapine does not influence pituitary–gonadal axis hormone levels in male schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in Schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Diurnal changes in paraventricular hypothalamic alpha1 and alpha2-adrenoceptors and food intake in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Brain histamine and feeding behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Mechanism of the body weight increase induced by systemic sulpiride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Atypical antipsychotics and weight gain--a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Elevation of prolactin levels by atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Norepinephrine and the control of food intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021

Bodyweight gain with atypical antipsychotics. A comparative review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300949

7 January 2021